Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Identify the lowest expense ratio among dividend etfs quickly and compare key funds side by side to guide your next investment move.
27,594 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
XRP traders are watching a ripple price alert: last signal that historically preceded a major rally. Analysts caution...
ZachXBT has named Axiom in a probe over alleged insider trading by an employee. Axiom paused internal tools and says ...
President Donald Trump escalated tensions with Spain by threatening a broad trade squeeze after Madrid refused to len...
Oracle is reshaping its business from database software to a cloud infrastructure powerhouse, fueled by surging backl...
Investors are weighing CoreWeave against top AI stocks. This guide explains the risks, introduces three solid alterna...
Circle has delivered a dramatic swing in 2024. This article breaks down the main reason it could keep climbing, the r...
A major reshuffle around Microsoft and OpenAI could shift AI momentum in tech clouds. This article explains why amazo...
Tesla looks different than it did a few years ago. This article explains why here's tesla stock before 2031 might off...
Arm Holdings has surged 104% year-to-date, with the AI pivot and AGI CPU driving demand. Smart money sits near a spec...
A podcast recap attributes a Bezos stance to exempting the bottom half from federal income taxes, highlighting a broa...
Trading on world prediction markets before kickoff has eclipsed $2 billion, with Spain and France trading as the lead...